tiprankstipranks
STRATEC Biomedical AG (DE:SBS)
XETRA:SBS
Germany Market
SBS
STRATEC Biomedical
RESEARCH TOOLSreports
Want to see DE:SBS full AI Analyst Report?

STRATEC Biomedical (SBS) Financial Statements

6 Followers

STRATEC Biomedical Financial Overview

STRATEC Biomedical's market cap is currently €233.39M. The company's EPS TTM is €-0.27; its P/E ratio is -70.37; and it has a dividend yield of 2.71%. STRATEC Biomedical is scheduled to report earnings on May 11, 2026, and the estimated EPS forecast is €0.19. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Mar 25Dec 23Dec 22Dec 21
Income Statement
Total Revenue€ 250.86M€ 257.62M€ 270.41M€ 274.63M€ 287.33M
Gross Profit€ 64.22M€ 76.39M€ 68.16M€ 79.49M€ 87.71M
Operating Income€ 8.59M€ 28.18M€ 28.12M€ 42.00M€ 49.63M
EBITDA€ 27.19M€ 47.34M€ 43.16M€ 57.53M€ 66.52M
Net Income€ -242.00K€ 16.02M€ 15.37M€ 29.22M€ 39.96M
Balance Sheet
Cash & Short-Term Investments€ 24.40M€ 48.73M€ 34.22M€ 24.07M€ 48.72M
Total Assets€ 443.38M€ 445.06M€ 466.58M€ 397.50M€ 368.52M
Total Debt€ 132.13M€ 130.53M€ 141.37M€ 87.15M€ 85.30M
Net Debt€ 109.08M€ 83.37M€ 107.84M€ 64.48M€ 38.11M
Total Liabilities€ 206.06M€ 202.53M€ 233.25M€ 172.32M€ 162.77M
Stockholders' Equity€ 237.32M€ 242.53M€ 233.33M€ 225.18M€ 205.76M
Cash Flow
Free Cash Flow€ -9.71M€ 30.52M€ 2.00M€ -8.74M€ 43.24M
Operating Cash Flow€ -433.00K€ 48.71M€ 19.43M€ 10.28M€ 63.47M
Investing Cash Flow€ -16.80M€ -15.97M€ -44.16M€ -19.00M€ -20.13M
Financing Cash Flow€ -6.30M€ -20.30M€ 35.44M€ -14.11M€ -34.33M
Currency in EUR

STRATEC Biomedical Earnings and Revenue History

Income Statement >

STRATEC Biomedical Debt to Assets

Balance Sheet >

STRATEC Biomedical Cash Flow

Cash Flow >

STRATEC Biomedical Forecast EPS vs Actual EPS

Earnings >